Portfolio Category: Current

NorthSea Therapeutics

NorthSea Therapeutics

Focused on the development of first-in-class therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.

Read More
Vascular Therapies

Vascular Therapies

Focused on the development of a drug-based solution to reduce the failure rate of AV Fistulas in dialysis patients.

Read More
Trellis Bioscience

Trellis Bioscience

Developer of CellSpot platform to derive therapeutic antibodies directly from the human immune system.

Read More
Resolve Therapeutics

Resolve Therapeutics

Focused on the development of a biologic therapy for Lupus and Sjögren’s Syndrome.

Read More
INTERlink AI

INTERlink AI

Provider of an automated solution for pharmacy pill-dispensing.

Read More
Oxyrane

Oxyrane

Focused on the development of next-generation enzyme replacement therapies for lysosomal storage diseases based on a yeast-based platform.

Read More
Ovizio Imaging Systems

Ovizio Imaging Systems

Provider of digital holographic microscopy technology.

Read More
Biomodal

Biomodal

Focused on the development of tools for epigenetic analysis.

Read More
zeotap GmbH

zeotap GmbH

Developer of a platform to allow telco operators to monetize their data securely and at scale.

Read More
VUV Analytics, Inc.

VUV Analytics, Inc.

Analytical instrumentation company focused on exploiting the vacuum UV band of the spectrum.

Read More
Vorago Technologies, Inc.

Vorago Technologies, Inc.

Provider of a patent-protected, process-based approach to harden semiconductor devices against radiation and thermal damage.

Read More
Novadip

Novadip

Focused on the development of therapies for hard and soft tissue reconstruction from autologous adipose stem cells.

Read More